Treatment of primary hypercholesterolaemia with simvastatin New Zealand multicentre evaluation-Reference-Cited by-同舟云学术

Treatment of primary hypercholesterolaemia with simvastatin New Zealand multicentre evaluation

Published:1991-10 Issue:7 Volume:155 Page:433-436
ISSN:0025-729X
Container-title:Medical Journal of Australia
language:en
Short-container-title:Medical Journal of Australia

Author:

Scott Russell S¹,Scott Russell S¹,Sharpe D Norman²,Nye Edwin R³,Sutherland Wayne H F³,Robertson M Clare³,Charleson Hamish⁴,French John K⁵,White Harvey D⁵,Reuben Stuart⁶,Maling Timothy J B⁷,Lewis Gerald R B⁸,Frampton Christopher⁹

Affiliation:

1. The Princess Margaret Hospital Christchurch 2 New Zealand

2. University of Auckland Medical School Auckland New Zealand

3. University of Otago Medical School Dunedin New Zealand

4. Waikato Hospital Hamilton New Zealand

5. Greenlane Hospital Auckland New Zealand

6. Southland Hospital Invercargill New Zealand

7. Wellington School of Medicine Wellington New Zealand

8. Napier Hospital Napier New Zealand

9. University of Canterbury Christchurch New Zealand

Publisher

AMPCo

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.5694/j.1326-5377.1991.tb93837.x

Reference19 articles.

1. Lipoproteins and the pathogenesis of atherosclerosis.

2. SERUM CHOLESTEROL, BLOOD PRESSURE, AND MORTALITY: IMPLICATIONS FROM A COHORT OF 361 662 MEN

3. The Lipid Research Clinics Coronary Primary Prevention Trial Results

4. Diet, Lipoproteins, and the Progression of Coronary Atherosclerosis

5. Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statin—Fibrate Combination Therapy;Annals of Pharmacotherapy;2001-07

2. Role of fibrates in the management of hypertriglyceridemia;The American Journal of Cardiology;1999-05

3. Long-term safety of statin-fibrate combination treatment in the management of hypercholesterolaemia in patients with coronary artery disease.;Heart;1995-07-01

4. Efficacy and safety of triple therapy(fluvastatin-bezafibrate-cholestyramine) for severe familial hypercholesterolemia;The American Journal of Cardiology;1995-07

5. The role of HMG-CoA reductase inhibitors in the treatment of hyperlipidemia: a review of fluvastatin;Current Therapeutic Research;1995-02